Article Versions Notes

Huynh S, Mortier L, Dutriaux C, Maubec E, Boileau M, Dereure O, Leccia M-T, Arnault J-P, Brunet-Possenti F, Aubin F, et al. Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study. Cancers. 2020; 12(6):1666. https://doi.org/10.3390/cancers12061666

Huynh, Sandra, Laurent Mortier, Caroline Dutriaux, Eve Maubec, Marie Boileau, Olivier Dereure, Marie-Therese Leccia, Jean-Philippe Arnault, Florence Brunet-Possenti, Francois Aubin, and et al. 2020. "Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study" Cancers 12, no. 6: 1666. https://doi.org/10.3390/cancers12061666

Huynh, S., Mortier, L., Dutriaux, C., Maubec, E., Boileau, M., Dereure, O., Leccia, M. -T., Arnault, J. -P., Brunet-Possenti, F., Aubin, F., Dreno, B., Beylot-Barry, M., Lebbe, C., Lefevre, W., & Delyon, J. (2020). Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study. Cancers, 12(6), 1666. https://doi.org/10.3390/cancers12061666